The National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health under the U.S. Department of Health and Human Services, has issued a forecasted grant opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)." This funding initiative reflects the NIH’s commitment to supporting research and technological innovation aimed at addressing health disparities across diverse populations in the United States.
The purpose of this forecasted opportunity is to solicit applications for the development of biomedical technologies specifically intended to mitigate disparities in healthcare access and health outcomes. These technologies are expected to be not only scientifically effective but also affordable, culturally and socially acceptable, and practically deliverable to underserved populations. Although applications are not yet being accepted, the early release of this notice is intended to allow researchers ample time to form collaborations and design comprehensive, responsive projects.
The funding mechanism for this initiative will be the R01 grant activity code, which typically supports health-related research and development based on the mission of the NIH. The opportunity is categorized under health-related discretionary funding and anticipates awarding up to two grants. The total estimated program funding for this initiative is $1,200,000 for the fiscal year 2027.
Eligible applicants include a broad spectrum of entities such as state and county governments, public and state-controlled institutions of higher education, independent school districts, federally recognized and non-federally recognized tribal governments and organizations, nonprofits with 501(c)(3) status (excluding institutions of higher education), public housing authorities, and both for-profit and small businesses. This inclusive eligibility framework underscores NIH’s aim to foster widespread innovation in reducing health disparities.
The forecast indicates that the official Notice of Funding Opportunity (NOFO) is expected to be published on November 21, 2025. Applications will be due by January 26, 2026, with award notifications anticipated by October 2, 2026. The projects funded through this initiative are expected to commence by December 1, 2026.
For more information or inquiries regarding this funding opportunity, interested parties are encouraged to contact Nichole Daringer at the National Institute of Biomedical Imaging and Bioengineering by phone at 301-451-4774 or via email at nichole.daringer@nih.gov.
